Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Praxis Precision Medicine Q3 EPS $(3.36) Beats $(3.43) Estimate

Author: Benzinga Newsdesk | November 05, 2025 08:04am
Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly losses of $(3.36) per share which beat the analyst consensus estimate of $(3.43) by 1.96 percent. This is a 22.18 percent decrease over losses of $(2.75) per share from the same period last year.

Posted In: PRAX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist